Top compounds associated with response to TLCD2


Feature Type Standardized
Nominal ANOVA
mRNA apicidin CTRPv2 pan-cancer AAC -0.075 0.03
mRNA indisulam CTRPv2 pan-cancer AAC -0.078 0.03
mRNA ceranib-2 CTRPv2 pan-cancer AAC -0.079 0.03
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.079 0.03
mRNA triptolide CTRPv2 pan-cancer AAC -0.085 0.03
mRNA SB-743921 CTRPv2 pan-cancer AAC -0.079 0.03
mRNA PD-0325901 CCLE pan-cancer AAC 0.11 0.03
mRNA CR-1-31B CTRPv2 pan-cancer AAC -0.077 0.03
mRNA JQ-1:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.077 0.03
mRNA Irinotecan CCLE pan-cancer AAC -0.14 0.03
Download CSV